The gap in the manufacturer channels is that NovoCare and LillyDirect dispense but do not prescribe. QuickMD fills exactly that gap, for $99.
$99 per weight-loss consultation, with no membership and no subscription. It prescribes Wegovy, Ozempic, Zepbound, Mounjaro and Rybelsus — branded only, with no compounded line at all.
What makes that interesting is the arithmetic when you combine it with a manufacturer pharmacy. A $99 consultation plus NovoCare's $149 Wegovy tablets is $248 for the first month and $149 thereafter, for an FDA-approved product with no recurring platform fee.
The assembled-route comparison
Branded Wegovy, assembled against bundled
| Route | First month | Ongoing |
|---|---|---|
| QuickMD consult + NovoCare tablets | $248 | $149/mo |
| Sesame (consult included) | $149 | $149/mo |
| NovoCare alone (prescription needed) | $149 | $149/mo |
| Mochi Health | $378 | $378/mo |
| Eden | $1,794 | $1,794/mo |
Scroll the table sideways to see every column.
Sesame beats the assembled route by bundling the consultation into the same $149, which makes it the more efficient option for Wegovy specifically. QuickMD's advantage is breadth: it prescribes Zepbound and Mounjaro too, where Sesame's cheapest published lines are semaglutide.
What it actually costs per year
Advertised prices in this category are usually medication only. Add the membership back in and the ranking changes. Pick a provider, or enter the quote you were given.
One-month semaglutide rate. Starting at $79/month equivalent requires a 12-month plan ($948 total); confirm payment and renewal terms.
- First month
- $139
- Every month after
- $139
- Total over 12 months
- $1,668
No membership on this plan, so every dollar goes to medication and care.
Figures are the providers' own published prices as of our last review of each. Promotional rates, multi-month prepayment and dose changes can all move these numbers — confirm at checkout.
What Wegovy is, and what it costs at source
Wegovy is semaglutide, approved by FDA for chronic weight management. In its registrational programme adults reached a 2.4 mg weekly maintenance dose and lost an average of about 15% of body weight over 68 weeks, with roughly one in three achieving 20%. It is also approved to reduce cardiovascular risk in adults with established cardiovascular disease, which is the narrow route by which Medicare can cover it at all.
The number that should anchor every Wegovy quote is Novo Nordisk's own self-pay price. NovoCare publishes tablets at $149 a month, the 0.25 mg and 0.5 mg injections at $199, the 1 mg to 2.4 mg maintenance doses at $349, and the 7.2 mg at $399 — with no membership and no prior authorisation.
Before you buy branded from a reseller
- Check the manufacturer's own price first — NovoCare for Wegovy, LillyDirect for Zepbound. Resale prices range across an order of magnitude.
- Establish whether a membership or programme fee is charged on top of the medication.
- Ask what the price is at your expected maintenance dose, since branded pricing usually rises with dose.
- If you have type 2 diabetes, ask about Ozempic or Mounjaro through insurance before paying cash for anything.
- Confirm whether the provider will submit a prior authorisation, and what happens if it is denied.